News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
The most recent Breast Cancer Research Digest by Dana-Farber
Photo from dana-farber.org
Oct 2, 2024, 14:56

The most recent Breast Cancer Research Digest by Dana-Farber

Dana-Farber’s Breast Oncology Center shared a post on X:

“Here’s the most recent Breast Cancer Research Digest – a summary of last week’s publications from select high-impact journals (September 23rd-29th, 2024).”

Source: Dana-Farber’s Breast Oncology Center/X

“Summary of quality of life in the ASCENT phase 3 clinical trial for people with metastatic triple-negative breast cancer.”

Loibl S, et al. Future Oncol. 2024 Sep 26

The most recent Breast Cancer Research Digest by Dana-Farber

 

“Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).”

Michel AM, et al. BMC Med Inform Decis Mak. 2024 Sep 27

The most recent Breast Cancer Research Digest by Dana-Farber

“Patient-reported outcomes between whole-breast plus regional irradiation and whole-breast irradiation only in pN1 breast cancer after breast conserving surgery and taxane-based chemotherapy: A randomized phase 3 clinical trial (KROG 17-01)”

Kim N, et al. Int J Radiat Oncol Biol Phys, 2024 Sep 24

The most recent Breast Cancer Research Digest by Dana-Farber

“Stereotactic Radiosurgery for 1-10 Brain Metastases to avoid Whole-Brain Radiotherapy – Results of the CYBER-SPACE Randomized Phase 2 Trial.”

El Shafie RA, et al. Neuro Oncol. 2024 Sep 28

The most recent Breast Cancer Research Digest by Dana-Farber

“The Immune-Related 27-Gene Signature DetermalO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer”

Dugo M, et al. Clin Cancer Res. 2024 Sep 23

The most recent Breast Cancer Research Digest by Dana-Farber

“On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer”

Sinn BV, et al. Breast Cancer Res. 2024 Sep 24

The most recent Breast Cancer Research Digest by Dana-Farber

“National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer”

Kim LS, et al. Ann Surg Oncol. 2024 Sep 25

The most recent Breast Cancer Research Digest by Dana-Farber

“Role of the Surgeon in De-Escalating Emotion During a Breast Cancer Surgery Consultation: A Qualitative Study of Patients’ Experiences in Alliance A231701CD”

Saucke MC, et al. Ann Surg Oncol. 2024 Sep 25

The most recent Breast Cancer Research Digest by Dana-Farber

“Identifying Factors Predicting Margin Status After Mastectomy”

Woeste MR, et al. Ann Surg Oncol. 2024 Sep 26

The most recent Breast Cancer Research Digest by Dana-Farber

“The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer”

Vasigh M, et al. Ann Surg Oncol. 2024 Sep 27

The most recent Breast Cancer Research Digest by Dana-Farber

“Exploring clinical markers of Axon degeneration processes in Chemotherapy-induced peripheral neuropathy among young adults receiving vincristine or paclitaxel”

Knoerl R, et al. BMC Neurol. 2024 Sep 28

The most recent Breast Cancer Research Digest by Dana-Farber

“National Trends and In-Hospital Outcomes for Immediate Implant-Based Versus Autologous-Based Breast Reconstruction: A Propensity Score-Matched Analysis”

Esparham A, et al. Ann Surg Oncol. 2024 Sep 28

The most recent Breast Cancer Research Digest by Dana-Farber

“Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-C”

Godet I, et al. Nat Commun. 2024 Sep 28

The most recent Breast Cancer Research Digest by Dana-Farber

“Breastfeeding experiences among young breast cancer survivors: A survey study”

Sella T, et al. Cancer. 2024 Sep 29

The most recent Breast Cancer Research Digest by Dana-Farber

More posts featuring Dana-Farber on oncodaily.com

Ali Esparham Alissa Michel Breast Cancer Bruno Valentin Sinn cancer Dana-Farber Cancer Center Dana-Farber’s Breast Oncology Center Inês Godet Leah Kim Mahtab Vasigh Matteo Dugo Matthew Woeste Megan Saucke Nalee Kim OncoDaily Oncology Rami El Shafie Robert Knoerl Sibylle Loibl Tal Sella
Special Coverage
Blog
Dec 21, 2024, 12:18
NCI Symposium on Translational Technology for Global Health
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story
Blog
Dec 21, 2024, 11:24
Christy Brown: How many things can you dread more than 'your child has aggressive brain cancer?'
Blog
Dec 21, 2024, 11:18
Jose Fernando Moura: Pivotal SABCS24 summary hosted by Cancer Network
Blog
Dec 21, 2024, 11:18
Jérôme Salomon: President Macron, WHO Director-General and global health leaders inaugurate WHO Academy
Blog
Dec 21, 2024, 11:17
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Blog
Dec 21, 2024, 11:14
Mediamedic - Wenbin Zhou on Pyrotinib-based regimen in HER2-positive breast cancer